Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Archives of General Psychiatry|June 1, 1990
Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophreniaA R Doran, R Labarca, O M Wolkowitz, et al.
Scientific Reports|January 12, 2018
The Microwell-mesh: A high-throughput 3D prostate cancer spheroid and drug-testing platformE O Mosaad, K F Chambers, K Futrega, et al.
Psychiatry Research|August 1, 1985
Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholiaA Roy, D Pickar, M Linnoila, et al.
Communications Biology|January 5, 2021
A single day of TGF-β1 exposure activates chondrogenic and hypertrophic differentiation pathways in bone marrow-derived stromal cellsKathryn Futrega, Pamela G Robey, Travis J Klein, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acidA R Doran, J Boronow, D R Weinberger, et al.
Biological Psychiatry|February 15, 1989
Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVAA R Doran, D R Rubinow, O M Wolkowitz, et al.
Life Sciences|October 19, 1987
Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illnessO M Wolkowitz, D R Rubinow, A Breier, et al.
The Journal of Infectious Diseases|October 15, 2025
Evaluating the impact of unadjusted confounding and study design on estimated pathogen-attributable diarrhea incidence among children in the MAL-ED cohortCharlotte R Doran, James A Platts-Mills, Eric Houpt, et al.
Pageof 13